Basic information Safety Supplier Related

1-Phenyl-2,5,8,11-tetraoxatridecan-13-aMine

Basic information Safety Supplier Related

1-Phenyl-2,5,8,11-tetraoxatridecan-13-aMine Basic information

Product Name:
1-Phenyl-2,5,8,11-tetraoxatridecan-13-aMine
Synonyms:
  • 1-Phenyl-2,5,8,11-tetraoxatridecan-13-aMine
  • Benzyl-PEG4-amine
  • 2-[2-[2-(2-phenylmethoxyethoxy)ethoxy]ethoxy]ethanamine
  • BnO-PEG3-CH2CH2NH2
  • CAS_86770-76-5
  • H2N-(CH2CH2O)4-Bn
  • BnO-PEG3-CH2CH2NH2/3,6,9,12-Tetraoxatridecan-1-amine, 13-phenyl-
  • 3,6,9,12-Tetraoxatridecan-1-amine, 13-phenyl-
CAS:
86770-76-5
MF:
C15H25NO4
MW:
283.3633
Mol File:
86770-76-5.mol
More
Less

1-Phenyl-2,5,8,11-tetraoxatridecan-13-aMine Chemical Properties

Boiling point:
390.4±32.0 °C(Predicted)
Density 
1.061±0.06 g/cm3(Predicted)
storage temp. 
under inert gas (nitrogen or Argon) at 2–8 °C
form 
Liquid
pka
8.74±0.10(Predicted)
color 
Colorless to light yellow
More
Less

1-Phenyl-2,5,8,11-tetraoxatridecan-13-aMine Usage And Synthesis

Uses

Benzyl-PEG4-amine is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs[1].

Synthesis

86770-71-0

86770-76-5

Triphenylphosphine (59.7 g, 227.7 mmol) was slowly added to a stirred solution of azide 23 (55.2 g, 178.4 mmol) in anhydrous tetrahydrofuran (700 mL) at 0 °C. The reaction mixture was stirred continuously for 10 hours at room temperature. Subsequently, water (5.8 mL, 323.4 mmol) was added to hydrolyze the intermediate phosphorus adduct. After continued stirring for 10 hours, the reaction mixture was diluted with water (1000 mL) and washed with toluene (200 mL, twice). The aqueous phase was concentrated by evaporation to afford the target product 1-phenyl-2,5,8,11-tetraoxatridecan-13-amine (50.6 g, 91% yield). The product was characterized by 1HNMR (400 MHz, CD3OD): δ 7.11-7.29 (m, 5H), 4.51 (s, 2H), 3.55-3.64 (m, 12H), 3.43 (t, J=5.2Hz, 2H), 2.78 (t, J=5.2Hz, 2H).

IC 50

PEGs

References

[1] An S, et al. Small-molecule PROTACs: An emerging and promising approach for the development of targeted therapy drugs. EBioMedicine. 2018 Oct;36:553-562 DOI:10.1016/j.ebiom.2018.09.005

1-Phenyl-2,5,8,11-tetraoxatridecan-13-aMineSupplier

Jiangsu Aikon Biopharmaceutical R&D co.,Ltd.
Tel
025-66113011 17798518460
Email
cfzhang@aikonchem.com
9ding chemical ( Shanghai) Limited
Tel
4009209199
Email
sales@9dingchem.com
Borenpharm Co., Ltd
Tel
027-65563561
Email
sales@borenpharm.com
Zhengzhou Acme Chemical Co., Ltd.
Tel
0371-0371-55629727 13323845623
Email
2885676761@qq.com
Amadis Chemical Company Limited
Tel
571-89925085
Email
sales@amadischem.com